Evidence for processing of dolichol-linked oligosaccharides in patients with neuronal ceroid-lipofuscinosis.
In agreement with reports from other laboratories, we have shown that patients with the juvenile or late infantile forms of neuronal ceroid-lipofuscinosis (NCL) have greatly increased levels (5-fold to 20-fold) of dolichyl pyrophosphoryl oligosaccharides in their cerebral gray matter. Oligosaccharides containing 2 GlcNAc residues and 3 to 9 mannose residues were liberated by mild acid hydrolysis. The oligosaccharide profile given by brain tissue from 2 patients with infantile NCL was markedly different from that of late infantile and juvenile NCL brain, with Man9GlcNAc2 as the most abundant component and decreasing amounts of Man8- Man7- and Man6GlcNAc2. By contrast, Man5GlcNAc2 was the most abundant oligosaccharide present in all juvenile NCL brain samples analyzed. Both the susceptibility of the isolated Man5GlcNAc2 to endoglucosaminidase H digestion and permethylation analysis clearly indicated that it is not an intermediate in the biosynthesis of Glc3Man9GlcNAc2-PP-dolichol but has undergone catabolism, probably either in the endoplasmic reticulum or in the Golgi apparatus. Treatment of cultured skin fibroblasts for 7 days with N-methyldeoxynojirimycin, a potent inhibitor of the endoplasmic reticulum processing enzymes glucosidase I and II, resulted in an accumulation of the same Man5GlcNAc2-PP-dolichol species that was elevated in juvenile NCL brain. The level in untreated fibroblasts was undetectable, suggesting that inhibition of processing glucosidases has interfered with the regulation and compartmentalization of lipid-linked oligosaccharides.
Daniel
P F
PF
Department of Biochemistry, E. K. Shriver Center, Waltham, MA 02254.
Sauls
D L
DL
Boustany
R M
RM
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives*; D002240:Carbohydrate Sequence; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D004288:Dolichol Phosphates / Q000378:metabolism*; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D009472:Neuronal Ceroid-Lipofuscinoses / Q000378:metabolism*; D009844:Oligosaccharides / Q000378:metabolism*; D011104:Polyisoprenyl Phosphate Oligosaccharides / Q000378:metabolism*; D000520:alpha-Glucosidases / Q000187:drug effects / Q000378:metabolism*
D004288:Dolichol Phosphates; D009844:Oligosaccharides; D011104:Polyisoprenyl Phosphate Oligosaccharides; D017485:1-Deoxynojirimycin; C042059:glucosidase I; D000520:alpha-Glucosidases; D005944:Glucosamine; C033424:N-methyldeoxynojirimycin